- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Gilead Sciences Inc+ Add to Watchlist
GILD:US114.0800 USD 1.8100 1.61%
As of 20:10:00 ET on 06/01/2015.
Company Profile for Gilead Sciences Inc (GILD)
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company's primary areas of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.
Gilead Sciences Inc
Key Executives for Gilead Sciences Inc (GILD)
|John C MartinChairman/CEO||John F MilliganPresident/COO|
|Robin L WashingtonExec VP/CFO||Paul R CarterExec VP:Commercial Operations|
|Gregg H AltonExec VP:Corp & Medical Affairs||Norbert W BischofbergerExec VP:Research & Dev/CSO|
|Patrick O'BrienVP:Investor Relations|